These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma. Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352 [No Abstract] [Full Text] [Related]
5. Chemoembolization and bland embolization: a critical appraisal. Befeler AS Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274 [TBL] [Abstract][Full Text] [Related]
6. Management of hepatocellular carcinoma. Del Pozo AC; López P Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209 [TBL] [Abstract][Full Text] [Related]
7. Management of hepatocellular carcinoma in the age of liver transplantation. Martin AP Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691 [TBL] [Abstract][Full Text] [Related]
8. Liver tumors and loco-regional therapy. Vogel W Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251 [No Abstract] [Full Text] [Related]
9. Treatment of unresectable hepatocellular carcinoma. Bismuth H; Samuel D; Engerran L N Engl J Med; 1995 Sep; 333(13):878. PubMed ID: 7544440 [No Abstract] [Full Text] [Related]
10. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach. Schumacher G; Gebauer B J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898 [No Abstract] [Full Text] [Related]
12. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352 [TBL] [Abstract][Full Text] [Related]
13. More options and improved outcomes for hepatocellular carcinoma. Scoggins CR J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036 [No Abstract] [Full Text] [Related]
14. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902 [No Abstract] [Full Text] [Related]
15. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes? Di Bisceglie AM Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Tez M; Zulfikaroglu B Cancer; 2008 Jun; 112(12):2820-1; author reply 2821. PubMed ID: 18465802 [No Abstract] [Full Text] [Related]
17. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218 [TBL] [Abstract][Full Text] [Related]
19. Resection and liver transplantation for hepatocellular carcinoma. Llovet JM; Schwartz M; Mazzaferro V Semin Liver Dis; 2005; 25(2):181-200. PubMed ID: 15918147 [TBL] [Abstract][Full Text] [Related]